Archive

Faceted archive

199 documents matching

June 2026
IN FORCE CDSCO · Public Notice · 2026-06-29
1 CDSCO updated list of laboratories to conduct Performance evaluation of IVDs dated 29/06/2026 2026-Jun-29 661 KB
April 2026
IN FORCE CDSCO · Public Notice · 2026-04-22
8 COVID-19 vaccines approved in the country as on 22.04.2026 2026-Apr-23 536 KB
Biological E. Ltd.Cipla Ltd.
March 2026
IN FORCE CDSCO · Public Notice · 2026-03-13
14 Addendum to Doc No. CDSCO. IVD. FAQ. 04. 2022 dated 13.03.2026 2026-Mar-13 321 KB
January 2026
IN FORCE Import policy & restrictions ·? CDSCO · Public Notice · 2026-01-30
22 Draft Guidance document for Import of In-vitro diagnostic Medical device for stakeholders comment (dated 30.01.2026) 2026-Feb-02 2163 KB
August 2025
IN FORCE CDSCO · Public Notice · 2025-08-11
55 COVID-19 vaccines approved in the country as on 11.08.2025 2025-Aug-11 477 KB
Biological E. Ltd.Cipla Ltd.
IN FORCE Import policy & restrictions ·? CDSCO · Public Notice · 2025-08-04
56 surrender RC letter dated 04.08.2025 (M/s. NKG Advisory Business and Consulting Services Pvt. Ltd) 2025-Aug-05 382 KB
NKG Advisory Business and Consulting Services Pvt. Ltd.
June 2025
IN FORCE CDSCO · Public Notice · 2025-06-04
66 CDSCO updated list of laboratories to conduct Performance evaluation of IVDs dated 04.06.2025 2025-Jun-04 617 KB
April 2025
IN FORCE CDSCO · Public Notice · 2025-04-11
49 Corrigendum to the letter dated 11.04.2025 on manufacturing and marketing of unapproved FDCs 2025-Sep-10 433 KB
March 2025
IN FORCE CDSCO · Public Notice · 2025-03-12
80 PAC Cancellation letter dated 12.03.2025 FSN brands Marketing Pvt Ltd 2025-Mar-12 257 KB
Amendment in the RC No. RC/COS-002272 valid upto 03-Mar-2026 of the Cosmetics
Fsn Brands Marketing Pvt. Ltd.
April 2024
IN FORCE CDSCO · Public Notice · 2024-04-22
110 Stakeholder consultation for feedback on SEC meetings dated 22.04.2024 2024-Apr-22 272 KB
IN FORCE CDSCO · Public Notice · 2024-04-15
103 Public Notice regarding DCGI meeting with Stakeholders Dated 15.04.2024 for 2nd and 4th July 2024 Meeting cancellation 2024-Jul-01 176 KB
IN FORCE CDSCO · Public Notice · 2024-04-15
112 Public Notice regarding DCGI meeting with Stakeholders Dated 15.04.2024 for 18 April 2024 Meeting cancellation 2024-Apr-15 143 KB
IN FORCE CDSCO · Public Notice · 2024-04-08
114 Public Notice regarding DCGI meeting with Stakeholders Dated 08.04.2024 for 16 April 2024 Meeting cancellation 2024-Apr-08 142 KB
IN FORCE CDSCO · Public Notice · 2024-04-05
118 Meeting through WebEx Video-conference of the DTAB-sub Committee on 05.04.2024 at 11.00 a.m. to 6:00 p.m. to Evaluation of 16 FDCs which were earlier considered as irrational in the Expert Committ
March 2024
IN FORCE CDSCO · Public Notice · 2024-03-26
117 Public Notice regarding DCGI meeting with Stakeholders Dated 26.03.2024 for 28 march 2024 Meeting cancellation 2024-Mar-26 142 KB
IN FORCE CDSCO · Public Notice · 2024-03-06
120 Public Notice regarding DCGI meeting with Stakeholders Dated 06.03.2024 2024-Mar-06 106 KB
February 2024
IN FORCE CDSCO · Public Notice · 2024-02-26
122 Public Notice No. Admin-A012(12)/46/2024-eoffice dated 26.02.2024 2024-Feb-26 63 KB
IN FORCE CDSCO · Public Notice · 2024-02-15
123 Public Notice dated 15.02.2024 2024-Feb-14 568 KB
January 2024
IN FORCE CDSCO · Public Notice · 2024-01-31
125 SEC-IND Office order dated 31.01.2024 2024-Jan-31 182 KB
October 2023
IN FORCE Procedural & compliance ·? CDSCO · Public Notice · 2023-10-12
142 Clarification on the Circular no. 29/Misc/03/2023-DC(344) dated 12.10.2023 2023-Oct-12 22 KB
Clarification on the Regulation of all Class C & D Medical Devices under Licensing regime, w.e.f 01.10.2023, as per G.S.R. 102(E) dt 11.02.2020- Regarding.
September 2023
IN FORCE CDSCO · Public Notice · 2023-09-26
144 CDSCO updated list of laboratories to conduct Performance evaluation of IVDs dated 26.09.2023 2023-Sep-29 654 KB
April 2023
IN FORCE Procedural & compliance ·? CDSCO · Public Notice · 2023-04-12
155 Circular for Licensing of Class C D medical devices dated 12.04.2023 2023-Apr-12 310 KB
January 2023
IN FORCE CDSCO · Public Notice · 2023-01-25
162 Rapid / CLIA / ELISA Kits approved for testing of Covid-19 as on 25.01.2023 2023-Jan-25 540 KB
CPC Diag. Pvt. Ltd.ImmunoshopIndia Pvt. Ltd.Athenese Dx Pvt. Ltd.
IN FORCE CDSCO · Public Notice · 2023-01-25
163 PCR Kits approved for testing of Covid-19 as on 25.01.2023 2023-Jan-25 512 KB
Lab Genomics Co. Ltd.Life TechnologiesAthenese Dx Pvt. Ltd.
October 2022
IN FORCE Procedural & compliance ·? CDSCO · Public Notice · 2022-10-01
169 Regulation of all Class A & B Medical Devices under Licensing regime, w.e.f 01.10.2022, as per G.S.R. 102(E) dt 11.02.2020 2022-Sep-30 401 KB
September 2022
IN FORCE CDSCO · Public Notice · 2022-09-30
170 Notice regarding implementation of gazette notification vide GSR 754(E) dated 30.09.2022 2022-Sep-30 290 KB
IN FORCE CDSCO · Public Notice · 2022-09-26
72 Examination of 2nd assessment report of Prof. Kokate Committee by Drugs Technical Advisory Board (DTAB) in its meeting dated 26.09.2022 2025-Apr-11 3102 KB
April 2022
IN FORCE CDSCO · Public Notice · 2022-04-29
79 Surrender of lmport Registration Certificate under Cos-4A vide IRN/COS- 4N20221 000001 dated 29.04.2022 and I RN/COS- 4N20221 000006 dated 14.08.2022 2025-Mar-27 371 KB
NKG Advisory Business and Consulting Services Pvt. Ltd.NK Healthcare Pvt. Ltd.
March 2022
IN FORCE CDSCO · Public Notice · 2022-03-25
136 Surrender and Cancellation of Cosmetics Registration Certificate No. RC/COS-003067 dated 25.03.2022 (M/s. Abbott Health Care P Ltd) 2023-Nov-28 325 KB
Abbott Healthcare Pvt. Ltd.
February 2022
IN FORCE CDSCO · Public Notice · 2022-02-11
192 Rapid / CLIA / ELISA Kits approved for testing of Covid-19 as on 11.02.2022 2022-Feb-11 510 KB
CPC Diag. Pvt. Ltd.ImmunoshopIndia Pvt. Ltd.Athenese Dx Pvt. Ltd.
December 2021
IN FORCE CDSCO · Public Notice · 2021-12-10
195 Publice Notice dated 10.12.2021 2021-Dec-10 169 KB
IN FORCE CDSCO · Public Notice · 2021-12-09
196 PCR Kits approved for testing of Covid-19 as on 09.12.2021 2021-Dec-09 479 KB
Lab Genomics Co. Ltd.Life TechnologiesAthenese Dx Pvt. Ltd.
January 2013
IN FORCE Procedural & compliance ·? CDSCO · Public Notice · 2013-01-15
156 Clarification w.r.t. the new drug status of FDCs (Fixed Dose Combinations) which were scrutinized w.r.t. letter dated 15.1.2013 issued by this office and declared as rational 2023-Apr-05 22146 KB
Procedure to be followed for Subsequent applicant in respect of FDCs declared as rational by Prof. Kokate Committee and approved by DCG(I)-regarding.
Undated
IN FORCE CDSCO · Public Notice · undated
95 Inviting comments on standard IVD evaluation protocols drafted by ICMR and CDSCO 2025-Jan-02 2843 KB
IN FORCE Import policy & restrictions ·? CDSCO · Public Notice · undated
2 Sale of In-Vitro Fertilization media, reagents and related consumables used in Assisted Reproductive Technology procedures 2026-Jun-24 323 KB
Sale of In-Vitro Fertilization media, reagents and related consumables used in Assisted Reproductive Technology procedures
IN FORCE CDSCO · Public Notice · undated
2 List of Suspended Ethics Committee by CLA 2026-Jun-12 1584 KB
para-2.4.2
IN FORCE CDSCO · Public Notice · undated
100 Approved panel of experts for the Subject Expert Committees 2024-Aug-29 493 KB
IN FORCE CDSCO · Public Notice · undated
196 Evaluation of certain pre 1988 permitted Fixed Dose Combinations (FDCs) de novo for manufacture for sale in the country without due approval from Central Licensing Authority 2021-Dec-28 123 KB
IN FORCE CDSCO · Public Notice · undated
1 List of Debarment of Principal Investigators by CLA 2026-Jun-12 2691 KB
para-2.4.2 Healthcare Global Enterprises
IN FORCE CDSCO · Public Notice · undated
18 Testing Laboratories approved by Statas & UT in Form 37 of Drugs Rule 1945 and Cos 23 of Cosmetics Rule 2020 2026-Mar-10 455 KB
HS 88 Analys Lab Pvt. Ltd.Biocon Biosphere Ltd.Chalapathi institute of Pharmaceutical
IN FORCE Import policy & restrictions ·? CDSCO · Public Notice · undated
1 Prohibits to Import, manufacture, sale, distribution and use in any food producing animal rearing system of drug formulations containing 'Chloramphenicol or Nitrofurans drugs with immediate effect 2
Prohibits to Import, manufacture, sale, distribution and use in any food producing animal rearing system of drug formulations containing "Chloramphenicol! or Nitrofurans drugs with imediate effect.reg
IN FORCE CDSCO · Public Notice · undated
194 Vigil on the activities of distribution & sale of suspected spurious Tocilizumab 400 mg/20 ml Injections in India 2021-Dec-28 404 KB
Vigil on the activities of distribution & sale of suspected spurious Tocilizumab 400mg/20mlI Injections in India
Roche Products (India) Pvt. Ltd.Cipla Ltd.
IN FORCE CDSCO · Public Notice · undated
174 Classification of Medical Device Pertaining to non-sterile, non-powered, hand-held or hand-manipulated Surgical Instruments for general use intended to be used in various general surgical procedur
IN FORCE Procedural & compliance ·? CDSCO · Public Notice · undated
84 Submission of clinical trial site addition and change of principal Investigator applications through sugam portal 2025-Feb-24 57 KB
Submission of Clinical Trial Site Addition and change of Principal Investigator applications through SUGAM portal
IN FORCE CDSCO · Public Notice · undated
173 Report of National List of Essential Medicines 2022 2022-Sep-13 8599 KB
IN FORCE CDSCO · Public Notice · undated
62 DCGI Public Hearing Form for applicants 2025-Jul-07 563 KB
IN FORCE CDSCO · Public Notice · undated
102 PRO feedback form Internal and Pro feedback form External 2024-Jul-26 909 KB
IN FORCE Import policy & restrictions ·? CDSCO · Public Notice · undated
190 Revised Schedule for Public hearing at PRO, CDSCO (HQ) 2022-Feb-22 386 KB
IN FORCE CDSCO · Public Notice · undated
158 Evaluation of 16 Fixed Dose Combinations (FDCs) by DTAB Sub-Committee which were earlier considered as irrational in the Expert Commiteee report of the Prof.Kokate Committee 2023-Mar-31 4207 KB
IN FORCE CDSCO · Public Notice · undated
200 Notice regarding Review of regulatory regime for drug approval 2021-Oct-14 348 KB
Page 1 / 4 Next →